Sobre hepatitis por virus C, coinfección con HIV, diagnóstico y cobertura del tratamiento

Ricart, Javier J; Francos, José L.
Medicina (B.Aires) ; 77(3): 252-253, jun. 2017.
Artículo en Español | LILACS | ID: biblio-894472

Documentos relacionados

  1. Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.
  2. [On C virus hepatitis, HIV coinfection, diagnosis and treatment coverage].
  3. HIV influences clustering and intracellular replication of hepatitis C virus.
  4. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
  5. Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment.
  6. CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
  7. Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus.
  8. Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals.
  9. Neuropsychological effects of direct-acting antiviral treatment for Hepatitis C virus subjects: A systematic review.
  10. Dynamic m<sup>6</sup> A profiles reveal the role of YTHDC2-TLR2 signaling axis in Talaromyces marneffei infection.